Search - tctmd.com

Displaying 1 - 20 of 58

Sort: Relevancy | Date

Presentation TCT 2021

Role of Drug Eluting Technologies as Definitive Therapy

Presenter: Thomas Zeller

November 06, 2021

Presentation TCT 2019

Sustained Limus Release-Designed Drug-Eluting Balloons: Is This the Solution for the Potential Increased Mortality With Paclitaxel Devices When Treating the SFA?

Presenter: Thomas Zeller

September 27, 2019

Presentation TCT 2019

My Toughest BTK Case of the Year

Presenter: Thomas Zeller

September 25, 2019

Presentation TCT 2019

A Comparison of Multiple Short Stents With Long Stents for Femoral Popliteal Lesions: Results of the LOCOMOTIVE Trial of VascuFlex System (From B. Braun)

Presenter: Thomas Zeller

September 25, 2019

Presentation TCT 2017

DCB Under Development: Alternative Drugs and Local Delivery Methods

Presenter: Sahil A. Parikh, Thomas Zeller, William A. Gray

November 01, 2017

Presentation TCT 2017

DCB Versus DES for SFA Disease: Data Review and Future Clinical Trials

Presenter: Sahil A. Parikh, Thomas Zeller, Jihad A. Mustapha

November 01, 2017

Presentation TCT 2017

DCB for Long Lesions and Highly Calcified Vessels II: Are Outcomes Improved With Non-Atherectomy Approaches (Scoring, Cutting, Lithoplasty, and More)

Presenter: Sahil A. Parikh, Thomas Zeller, Peter A. Schneider

November 01, 2017

Presentation TCT 2017

DCB for Long Lesions and Highly Calcified Vessels I: Are Outcomes Improved by Routine Atherectomy?

Presenter: Sahil A. Parikh, Thomas Zeller, Krishna J. Rocha-Singh

November 01, 2017

Presentation TCT 2017

DCB Data in Specific Lesion Subsets: ISR, CTO, and Beyond

Presenter: Sahil A. Parikh, Thomas Zeller

November 01, 2017

Presentation TCT 2017

DCB Data in Real-world Registries: Back to Reality?

Presenter: Sahil A. Parikh, Thomas Zeller, Gary M. Ansel

November 01, 2017

Presentation TCT 2017

Impact of DCB Technique on Long-term Vessel Patency: Can Clinical Outcomes Be Optimized?

Presenter: William A. Gray, Thomas Zeller

November 01, 2017

Presentation TCT 2017

Long-term Data With Lower-Dose DCB Technologies (LEVANT, ILLUMINATE, RANGER)

Presenter: William A. Gray, Thomas Zeller, Mitchell Weinberg

November 01, 2017

Presentation TCT 2017

Long-Term Data With Standard-Dose DCB Technologies (IN.PACT SFA and the Consequent Trial)

Presenter: William A. Gray, Thomas Zeller, Peter A. Schneider

November 01, 2017

Presentation TCT 2017

DCB Architecture: Technical Features Determining Long-term Safety and Efficacy

Presenter: William A. Gray, Thomas Zeller, Juan F. Granada

November 01, 2017

Presentation TCT 2017

Multilevel Disease: How Does BTK Disease Affect ATK Therapy?

Presenter: D. Christopher Metzger, Thomas Zeller, Tony Das

October 31, 2017

Presentation TCT 2017

Treating Long, Calcified Lesions, the Achilles Heel for Endovascular Therapy

Presenter: D. Christopher Metzger, Thomas Zeller, Nicolas W Shammas

October 31, 2017

Presentation TCT 2017

Does Lesion Length Affect Treatment Choice in the Fem-pop Segment?

Presenter: D. Christopher Metzger, Thomas Zeller, William A. Gray

October 31, 2017

Presentation TCT 2017

Crossing and Treating Long Lesions: Does the True Lumen Matter for Drug Delivery?

Presenter: D. Christopher Metzger, Thomas Zeller

October 31, 2017

Presentation TCT 2017

Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization DESappear Study Initial Results

Presenter: Tony Das, Thomas Zeller

October 30, 2017

Presentation TCT 2017

Percutaneous Femoropopliteal Bypass Using the Novel PQ Bypass DETOUR Procedure for Long-Segment Disease: Interim Safety and Efficacy Data from the DETOUR I Trial

Presenter: Tony Das, Thomas Zeller, Grzegorz Halena, MD

October 30, 2017

Advertisement

Role of Drug Eluting Technologies as Definitive Therapy

Sustained Limus Release-Designed Drug-Eluting Balloons: Is This the Solution for the Potential Increased Mortality With Paclitaxel Devices When Treating the SFA?

My Toughest BTK Case of the Year

A Comparison of Multiple Short Stents With Long Stents for Femoral Popliteal Lesions: Results of the LOCOMOTIVE Trial of VascuFlex System (From B. Braun)

DCB Under Development: Alternative Drugs and Local Delivery Methods

DCB Versus DES for SFA Disease: Data Review and Future Clinical Trials

DCB for Long Lesions and Highly Calcified Vessels II: Are Outcomes Improved With Non-Atherectomy Approaches (Scoring, Cutting, Lithoplasty, and More)

DCB for Long Lesions and Highly Calcified Vessels I: Are Outcomes Improved by Routine Atherectomy?

DCB Data in Specific Lesion Subsets: ISR, CTO, and Beyond

DCB Data in Real-world Registries: Back to Reality?

Impact of DCB Technique on Long-term Vessel Patency: Can Clinical Outcomes Be Optimized?

Long-term Data With Lower-Dose DCB Technologies (LEVANT, ILLUMINATE, RANGER)

Long-Term Data With Standard-Dose DCB Technologies (IN.PACT SFA and the Consequent Trial)

DCB Architecture: Technical Features Determining Long-term Safety and Efficacy

Multilevel Disease: How Does BTK Disease Affect ATK Therapy?

Treating Long, Calcified Lesions, the Achilles Heel for Endovascular Therapy

Does Lesion Length Affect Treatment Choice in the Fem-pop Segment?

Crossing and Treating Long Lesions: Does the True Lumen Matter for Drug Delivery?

Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization DESappear Study Initial Results

Percutaneous Femoropopliteal Bypass Using the Novel PQ Bypass DETOUR Procedure for Long-Segment Disease: Interim Safety and Efficacy Data from the DETOUR I Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content